The global nucleic acid isolation and purification market is estimated to grow at a CAGR of more than 8.0% during the forecast period. Emerging demand for personalized medicines is offering an opportunity for market growth. Increasing US FDA approvals for personalized medicines supporting the growth in genomics researches. For instance, as per the Personalized Medicine Coalition, in 2018, 25 of the 59 new molecular entities (NMEs) FDA approved are personalized medicines, which is 42% of all new drug approvals. In 2017, 34% of NMEs were classified by the Coalition as personalized medicines, whereas it was 28% in 2015; 27% in 2016.
Considerable public and private investment for genomics and proteomics researches are providing support to the biotechnology start-ups and research institutes. This enables healthcare providers to develop and commercialize genomics technologies and personalized medicines. This results in the development of personalized medicine as an emerging practice of medicine that utilizes the genetic profile of an individual which supports to make appropriate decisions regarding prevention, diagnosis, and treatment of the condition. Gaining complete knowledge of a patient's genetic profile assists doctors to opt for the proper therapy or medication and administer it utilizing the proper regimen or dose.
Browse the full report description of "Global Nucleic Acid Isolation and Purification Market Size, Share & Trends Analysis Report, By Method (Column Based, Magnetic Beads, Reagent Based, and Others), By Product (Reagents and Kits, and Instruments), By Type (DNA and RNA), By Application, By End-User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Others) and Forecast, 2019-2025" at https://www.omrglobal.com/industry-reports/nucleic-acid-isolation-and-purification-market
Owing to the emerging focus on personalized medicine and gene-editing, a significant rise in the adoption of reliable and efficient DNA and RNA isolation techniques have been witnessed that can yield sufficient amount of high-quality DNA with fewer impurities. Molecular diagnostic tests are used for the development of tailored customer treatments as it enables to get a new understanding regarding the genetic composition of several types of cancer. The quality of the results is a crucial aspect in molecular diagnostics, which significantly depends upon the quality of genetic material used, such as DNA and RNA. Therefore, there is a considerable demand for reliable, faster, and automated solutions to extract nucleic acids, including DNA and RNA without affecting the quality.
As a result, the manufacturers of nucleic acid isolation and purification products are working on novel extraction technology for application in personalized medicine. For instance, Exscale Biospecimen Solutions AB offers next-generation extraction technology named NGEx to extract nucleic acid and increase productivity for personalized medicine. Sequential DNA and RNA extraction technology have a significant role to encourage the development of personalized medicine for cancer patients. Therefore, the emerging development of personalized medicine is creating significant scope for the growth of the global nucleic acid isolation and purification market.
Global Nucleic Acid Isolation and Purification Market- Segmentation
By Method
By Product
By Type
By Application
By End-User
Global Nucleic Acid Isolation and Purification Market– Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/nucleic-acid-isolation-and-purification-market